NEJM (The New England Journal of Medicine)

Kanalga Telegram’da o‘tish

All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

Ko'proq ko'rsatish

AQSH1 458 Tibbiyot783...

📈 Telegram kanali NEJM (The New England Journal of Medicine) analitikasi

NEJM (The New England Journal of Medicine) (@the_nejm) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 26 718 obunachidan iborat bo'lib, Tibbiyot toifasida 783-o'rinni va AQSH mintaqasida 1 458-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 26 718 obunachiga ega bo‘ldi.

20 Iyul, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 359 ga, so‘nggi 24 soatda esa 5 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

Tasdiqlash holati: Tasdiqlanmagan
Jalb etish (ER): Auditoriya o‘rtacha 6.90% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 2.76% ini tashkil etuvchi reaksiyalarni to‘playdi.
Post qamrovi: Har bir post o‘rtacha 1 843 marta ko‘riladi; birinchi sutkada odatda 736 ta ko‘rish yig‘iladi.
Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 2 ta reaksiya keladi.
Tematik yo‘nalishlar: Kontent medicine, journal, print, cancer, patient kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicin...”

Yuqori yangilanish chastotasi (oxirgi ma’lumot 21 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

26 718

Obunachilar

+524 soatlar

+807 kunlar

+35930 kunlar

1 843

Post ko'rishlar

~ 73624 soatlar

~ 95448 soatlar

6.90%

Muloqot nisbati

~ 2

Kuniga postlar

Ads index

beta

Postlar arxiv

26 718

When Celebrities Prescribe — Regulating Drug Promotion on the Internet https://www.nejm.org/doi/full/10.1056/NEJMp2602486?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Love and Death https://www.nejm.org/doi/full/10.1056/NEJMp2516818?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

National Elimination of Hepatitis C — The Case for Starting in Prisons and Jails https://www.nejm.org/doi/full/10.1056/NEJMp2602773?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Neurocysticercosis https://www.nejm.org/doi/full/10.1056/NEJMicm2603020?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection https://www.nejm.org/doi/full/10.1056/NEJMp2605103?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease https://www.nejm.org/doi/full/10.1056/NEJMoa2517588?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 233-242, July 16, 2026.

26 718

Lead Lines in Severe Lead Poisoning https://www.nejm.org/doi/full/10.1056/NEJMicm2603074?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 290-290, July 16, 2026.

26 718

Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma https://www.nejm.org/doi/full/10.1056/NEJMe2604761?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 302-303, July 16, 2026.

26 718

Targeted Degradation of NETs in Lupus with DNASE1L3 Deficiency https://www.nejm.org/doi/full/10.1056/NEJMc2601997?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 308-310, July 16, 2026.

26 718

Large-Scale Premarital Genetic Screening in the United Arab Emirates https://www.nejm.org/doi/full/10.1056/NEJMc2510402?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 306-308, July 16, 2026.

26 718

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis https://www.nejm.org/doi/full/10.1056/NEJMc2602619?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 3, Page 311-312, July 16, 2026.

26 718

Andes Virus — A Clinical Review https://www.nejm.org/doi/full/10.1056/NEJMra2606651?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

A Regional Measles Outbreak — South Carolina, 2025–2026 https://www.nejm.org/doi/full/10.1056/NEJMc2605131?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

NEJM This Week — July 16, 2026 http://www.nejm.org/toc/nejm/395/3 This week, we present advances in the treatment of multiple myeloma, systemic lupus erythematosus, and coronary artery disease, alongside new national data on health care–associated infections. We also review fibromyalgia and the emerging Bundibugyo virus outbreak, follow a surprising diagnostic case of alpha-gal syndrome, and explore Perspectives on caring for vulnerable patients, trustworthy health information, pharmacotherapeutic decisions in autism care, and the experience of caring for a parent with dementia.

26 718

NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care. http://www.nejm.org/doi/full/10.1056/NEJMp2602649 Yaara Zisman-Ilani is an associate professor in the Department of Social and Behavioral Sciences at the Barnett College of Public Health and in the Department of Psychiatry and Behavioral Science at the Lewis Katz School of Medicine, both at Temple University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Zisman-Ilani and Others. Pharmacotherapeutic Decisions in Autism. N Engl J Med 2026;395:214-217.

26 718

Platelet-Activating Anti–Platelet Factor 4 Disorders https://www.nejm.org/doi/full/10.1056/NEJMra2502459?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty https://www.nejm.org/doi/full/10.1056/NEJMoa2603649?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Pharmacotherapeutic Decisions in Autism https://www.nejm.org/doi/full/10.1056/NEJMp2602649?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

Descending Thoracic Aortic Aneurysm https://www.nejm.org/doi/full/10.1056/NEJMicm2505469?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

26 718

The Exam Room as Sanctuary — Caring for Undocumented Patients https://www.nejm.org/doi/full/10.1056/NEJMp2603126?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.